Clinical Trials on Glycogen Storage Disease Type II-Pompe's Disease in Switzerland
Total 1142 results
-
European Organisation for Research and Treatment...TerminatedMetastatic Cancer | Intraocular MelanomaSwitzerland, Italy, United Kingdom, Poland
-
Novartis PharmaceuticalsCompletedPigmented Villonodular Synovitis | PVNS | Giant Cell Tumor of the Tendon Sheath | GCCTS | Tenosynovial Giant Cell Tumor Localized or Diffused Type | GCTSUnited States, Switzerland
-
Swiss Group for Clinical Cancer ResearchCompletedGastrointestinal Stromal TumorFrance, Switzerland, Germany, Finland
-
CelgeneTriphaseCompletedGlioblastoma | Malignant GliomaUnited States, Canada, Switzerland
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingAcute Lymphoblastic Leukemia | Down Syndrome | Philadelphia Chromosome Positive | Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 | Childhood B Acute Lymphoblastic Leukemia | Adult B Lymphoblastic Lymphoma | Ann Arbor Stage I B Lymphoblastic Lymphoma | Ann Arbor Stage... and other conditionsUnited States, Canada, Puerto Rico, Australia, New Zealand, Switzerland, Ireland
-
SanofiRecruitingFabry DiseaseChina, Finland, Germany, Norway, United Kingdom, United States, Denmark, Austria, Greece, Romania, Argentina, Brazil, Canada, Japan, Mexico, Poland, Italy, France, Turkey, Australia, Switzerland
-
Philogen S.p.A.RecruitingGlioblastomaFrance, Germany, Italy, Switzerland
-
Novartis PharmaceuticalsCompletedMedulloblastoma | Basal Cell Carcinoma | Advanced Solid Tumor CancersSpain, Switzerland, United Kingdom, United States
-
Swiss Group for Clinical Cancer ResearchTerminatedAdenocarcinoma | Breast CancerSwitzerland
-
University Hospital, GrenobleCompletedDiabetes Mellitus, Type 1France, Switzerland
-
Boehringer IngelheimRecruitingGliomaSpain, United States, Germany, Netherlands, Austria, Switzerland
-
Swiss Group for Clinical Cancer ResearchCompleted
-
Debiopharm International SARecruitingAstrocytoma, Grade III | Glioblastoma IDH (Isocitrate Dehydrogenase) WildtypeSpain, United States, Switzerland
-
Swiss Group for Clinical Cancer ResearchEuropean Mantle Cell Lymphoma NetworkTerminatedMantle Cell LymphomaItaly, Germany, Switzerland
-
University Hospital, Basel, SwitzerlandBristol-Myers Squibb; Swiss National Science FoundationCompletedHIV Infection | Dyslipidemia | Coronary Heart Disease | Diabetes Mellitus, Non-Insulin-DependentSwitzerland
-
Hoffmann-La RocheCompletedCarcinoma, Non-Small-Cell Lung | Carcinoma, Small CellUnited Kingdom, Czechia, Germany, Poland, Spain, Switzerland
-
Genzyme, a Sanofi CompanyRecruitingGaucher Disease | Cerebroside Lipidosis Syndrome | Glucocerebrosidase Deficiency Disease | Glucosylceramide Beta-Glucosidase Deficiency DiseaseHungary, Croatia, United States, Australia, Belgium, Brazil, Bulgaria, Canada, Denmark, Germany, Greece, Hong Kong, India, Indonesia, Italy, Jordan, Korea, Republic of, Kuwait, Lebanon, Malaysia, Pakistan, Philippines, Poland, Saudi Arabia and more
-
PharmaMarCompletedLymphoma | LeukemiaItaly, France, Switzerland, Spain, Peru, Puerto Rico
-
Lymphoma Study AssociationCompletedDiffuse Large Cell LymphomaFrance, Belgium, Switzerland
-
Terumo Europe N.V.CompletedHepatocellular Carcinoma | Metastatic CancerNetherlands, Germany, Switzerland, Belgium, Spain, Portugal, Italy
-
Erasmus Medical CenterUniversitaire Ziekenhuizen KU Leuven; University of California, San Francisco; Medical Center HaaglandenRecruitingGlioblastomaUnited States, Belgium, Germany, Netherlands, Switzerland
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLymphomaPuerto Rico, United States, Switzerland
-
University of ZurichCompletedPituitary AdenomaSwitzerland, United States, Austria, Canada, Czechia, Italy
-
Novartis PharmaceuticalsRecruitingGlioblastoma Multiforme | Gastroesophageal Adenocarcinoma | Pancreatic Ductal AdenocarcinomaNetherlands, Spain, Israel, United States, Switzerland
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumors | Recurrent or Refractory Medulloblastoma | Locally Advanced or Metastatic Basal Cell CarcinomaUnited States, United Kingdom, Switzerland, Netherlands
-
ETOP IBCSG Partners FoundationMerck Sharp & Dohme LLC; Frontier Science Foundation, HellasCompletedPleural Mesothelioma Malignant AdvancedUnited Kingdom, Switzerland, Spain
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Austria, Switzerland, United Kingdom, Germany, Ireland
-
Swiss Group for Clinical Cancer ResearchCompletedLymphomaFrance, Switzerland, Italy
-
Basilea PharmaceuticaCompletedNeoplasmsBelgium, United Kingdom, Germany, Switzerland
-
Prof. Dr. Wolfgang WickEssex Pharma GmbHCompletedGlioblastomaGermany, Austria, Switzerland
-
Novartis PharmaceuticalsTerminatedRenal Cell Carcinoma | Epithelial Ovarian CancerJapan, Australia, Belgium, Spain, United States, Switzerland
-
European Organisation for Research and Treatment...CompletedLymphomaGermany, Switzerland, Israel, United Kingdom, Austria, Italy
-
Lymphoma Study AssociationAmgenCompletedDiffuse Large Cell LymphomaFrance, Belgium, Switzerland
-
Swiss Group for Clinical Cancer ResearchActive, not recruitingNon-small Cell Lung Cancer | Malignant Pleural MesotheliomaSwitzerland
-
Swiss Group for Clinical Cancer ResearchGerman Testicular Cancer Study GroupActive, not recruitingSeminoma | Testicular CancerGermany, Switzerland
-
SandozHexal AGCompletedChronic Kidney Disease | End-stage Renal Disease | AnaemiaAustria, France, Germany, Italy, Poland, Romania, Slovenia, Spain, Switzerland, United Kingdom
-
Boston Scientific CorporationBiocompatibles UK LtdCompletedPrimary Liver CancerAustria, Switzerland, France, Germany
-
International Extranodal Lymphoma Study Group (IELSG)CompletedCentral Nervous System LymphomaGermany, Italy, United Kingdom, Switzerland
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Switzerland
-
European Organisation for Research and Treatment...CompletedLymphomaFrance, Netherlands, Belgium, United Kingdom, Egypt, Switzerland, Portugal
-
University of BirminghamRoche Pharma AG; Cancer Research UK; Imagine for Margo; EUSA Pharma, Inc.Active, not recruitingNeuroblastomaFrance, Austria, Belgium, Denmark, Ireland, Italy, Spain, Switzerland, United Kingdom, Netherlands
-
ETOP IBCSG Partners FoundationUSZ FoundationRecruitingMelanoma | Non-Small Cell Lung CancerSwitzerland, Netherlands, Italy, United Kingdom
-
CelgeneJunoWithdrawnPrecursor Cell Lymphoblastic Leukemia-LymphomaBelgium, France, Spain, Italy, Germany, Switzerland, United Kingdom
-
EUROSPK Study GroupWyeth is now a wholly owned subsidiary of Pfizer; Hoffmann-La Roche; Genzyme,... and other collaboratorsCompletedDiabetes Mellitus, Type 1 | Diabetic NephropathyBelgium, Israel, Germany, Austria, Czechia, Spain, Switzerland
-
Bristol-Myers SquibbCompletedHigh Risk Stage III MelanomaItaly, Poland, United Kingdom, United States, Netherlands, Spain, Australia, France, Germany, Canada, Russian Federation, Belgium, Norway, Switzerland, Sweden, Finland, Austria, Denmark, Czechia
-
International Extranodal Lymphoma Study Group (IELSG)CompletedPrimary Mediastinal B-Cell LymphomaItaly, United Kingdom, Switzerland, Spain
-
Gustave Roussy, Cancer Campus, Grand ParisCompletedLymphomaFrance, Spain, Italy, Belgium, Germany, Switzerland, Austria, United Kingdom, Netherlands, Sweden
-
University of GiessenDeutsche Krebshilfe e.V., Bonn (Germany); Euronet WorldwideActive, not recruitingClassical Hodgkin LymphomaUnited Kingdom, Australia, Austria, Belgium, Czechia, Denmark, France, Germany, Ireland, Israel, Italy, Netherlands, New Zealand, Norway, Poland, Slovakia, Spain, Sweden, Switzerland
-
Clinuvel Pharmaceuticals LimitedUnknownCarcinoma, Squamous Cell | Actinic Keratoses | Organ Transplant RecipientsAustralia, Sweden, Switzerland, Italy, France, Belgium, Germany
-
Gustave Roussy, Cancer Campus, Grand ParisInnovative Therapies For Children with Cancer ConsortiumTerminatedRefractory Low-grade Gliomas | Recurrent Low-grade GliomasAustria, Italy, France, Denmark, Netherlands, Spain, Switzerland, United Kingdom